UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000057726
Receipt number R000065962
Scientific Title Retrospective study on the clinical outcomes of minimally invasive local treatment for early-stage breast cancer
Date of disclosure of the study information 2025/04/26
Last modified on 2025/04/26 14:41:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Retrospective study on the clinical outcomes of minimally invasive local treatment for early-stage breast cancer

Acronym

Retrospective study on the clinical outcomes of minimally invasive local treatment for early-stage breast cancer

Scientific Title

Retrospective study on the clinical outcomes of minimally invasive local treatment for early-stage breast cancer

Scientific Title:Acronym

Retrospective study on the clinical outcomes of minimally invasive local treatment for early-stage breast cancer

Region

Japan


Condition

Condition

Early breast cancer

Classification by specialty

Breast surgery Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study aims to evaluate the clinical significance of the efficacy of less invasive local therapy for early-stage breast cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Efficacy, safety, validation, etc.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

All patients receiving any treatment for breast cancer

Key exclusion criteria

none

Target sample size

3500


Research contact person

Name of lead principal investigator

1st name Kazuhiko
Middle name
Last name Sato

Organization

Tokyo-West Tokushukai Hospital

Division name

Department of Breast Oncology

Zip code

196-0003

Address

3-1-1 Matsubara, Akishima, Tokyo

TEL

0425004433

Email

kazsato.boc@gmail.com


Public contact

Name of contact person

1st name Kazuhiko
Middle name
Last name Sato

Organization

Tokyo-West Tokushukai Hospital

Division name

Department of Breast Oncology

Zip code

196-0003

Address

3-1-1 Matsubara, Akishima, Tokyo

TEL

09084344853

Homepage URL


Email

kazsato.boc@gmail.com


Sponsor or person

Institute

Clinical research center, Tokyo-West Tokushukai Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Mirai Iryo Research Center

Address

1-3-1 KUdan-minami, Chiyoda, Tokyo

Tel

03-3263-4801

Email

https://www.mirai-iryo.com/


Secondary IDs

Secondary IDs

YES

Study ID_1

TGE02745-060

Org. issuing International ID_1

Central IRB in Tokushukai Medical Group

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 04 Month 26 Day


Related information

URL releasing protocol

https://www.tokyonishi-hp.or.jp/dl/research/mammary-tumor_08.pdf

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 03 Month 27 Day

Date of IRB

2025 Year 03 Month 27 Day

Anticipated trial start date

2025 Year 04 Month 01 Day

Last follow-up date

2028 Year 08 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study


Management information

Registered date

2025 Year 04 Month 26 Day

Last modified on

2025 Year 04 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065962